KAIST 생명과학과동창회
  • News & Events
  • News

News

Antibiotic tolerance study paves way for new treatments

Posted on Mar 02, 2021, 3 p.m.


A new study identifies a mechanism that makes bacteria tolerant to penicillin and related antibiotics, findings that could lead to new therapies that boost the effectiveness of these treatments.


Antibiotic tolerance is the ability of bacteria to survive exposure to antibiotics, in contrast to antibiotic resistance, when bacteria actually grow in the presence of antibiotics. Tolerant bacteria can lead to infections that persist after treatment and may develop into resistance over time.


The study in mice, “A Multifaceted Cellular Damage Repair and Prevention Pathway Promotes High Level Tolerance to Beta-lactam Antibiotics,” published Feb. 3 in the journal EMBO Reports, reveals how tolerance occurs, thanks to a system that mitigates iron toxicity in bacteria that have been exposed to penicillin.


“We’re hoping we can design a drug or develop antibiotic adjuvants that would then basically kill off these tolerant cells,” said senior author Tobias Dörr, assistant professor of microbiology in the Weill Institute for Cell and Molecular Biology in the College of Agriculture and Life Sciences.


Co-authors included Ilana Brito, the Mong Family Sesquicentennial Faculty Scholar and assistant professor in the Meinig School of Biomedical Engineering in the College of Engineering, and Lars Westblade, associate professor of pathology and laboratory medicine at Weill Cornell Medicine.


Some bacteria, including the model bacterium used in the study, Vibrio cholerae, which causes cholera in humans, are remarkably tolerant to penicillin and related antibiotics, known as beta-lactam antibiotics. It has been known for a long time that beta-lactam antibiotics break down bacterial cell walls, but how bacteria survive loss of their cell walls was poorly understood.


In the study, the researchers developed a V. cholerae mutant that lacked a two-component damage repair response system that controls a gene network encoding diverse functions. Without the system, known as VxrAB, when the cell wall is damaged by antibiotics, the transfer of electrons across the cell membrane goes awry, leading to electrons ending up on the wrong molecules. This misdirection causes hydrogen peroxide to accumulate in the cell, which changes the oxidation state of cellular iron and disrupts signals for the cell to tell how much iron it has.  


In the presence of hydrogen peroxide, the mutant bacteria cannot sense how much iron has been acquired, and it behaves as if it is iron-starved and seeks to acquire more iron. Left unchecked, these circumstances cause iron toxicity, which will kill the cell, according to the experiments the researchers conducted. In further tests with mutant V. cholerae bacteria, both in test tubes and in mice, the researchers showed that reducing the influx of iron increased the bacteria’s tolerance to beta-lactams.


Fortunately for normal V. cholerae, exposure to antibiotics and the breakdown of the cell’s walls activate the VxrAB system, which works to repair cell walls and downregulates iron uptake systems, and thereby creates antibiotic tolerance. More study is needed to understand what triggers the VxrAB system in the presence of beta-lactam antibiotics.


The research opens the door for developing new drugs that could be combined with antibiotics to exploit oxidative damage and iron influx in tolerant bacteria. In future work, the researchers will search for parallel mechanisms of tolerance in other bacterial pathogens.


Jung-Ho Shin, a postdoctoral researcher in Dörr’s lab, is the paper’s first author. Co-authors include researchers from the Korea Advanced Institute of Science and Technology, the Korea Advanced Institute of Science and Technology, and the Intelligent Synthetic Biology Center in Korea.

The study was funded by the National Research Foundation of Korea and the National Institutes of Health.


https://www.worldhealth.net/news/antibiotic-tolerance-study-paves-way-new-treatments/


List of Articles
번호 제목 글쓴이 날짜 조회 수
360 [이주형 학부생] 포스텍SF 어워드에서 생명과학과 학부생 이주형, 단편 부문 가작 선정 생명과학과 2022.02.10 234
359 [김찬혁 교수님] 서울대병원, '꿈의 항암제' CAR-T 임상1상 본격 돌입 생명과학과 2022.02.04 283
358 [오병하 교수님] 오미크론에도 듣는 범용 항체, 국내에서 개발 생명과학과 2022.02.04 204
357 [정현정 교수님] 유전자 가위로 생체 내 정밀한 유전자 교정에 의한 면역 항암 치료​ 생명과학과 2022.01.18 332
356 [조병관 교수님] 한국연구재단, 노화 방지하고 회춘하는 방법 제시 생명과학과 2022.01.13 255
355 [조원기 교수님] 세포 기능 결정에 핵심 역할 유전자 발현 단백질 찾았다 생명과학과 2021.12.24 267
354 [진에딧 이근우 대표] 한국인이 세운 ‘유전자 가위’ 스타트업… 실리콘밸리가 침흘리는 이유 생명과학과 2021.12.20 296
353 [이승재 교수님] 국내 연구팀, 예쁜꼬마선충을 이용 새로운 항노화 단백질 찾아 생명과학과 2021.12.13 278
352 [허원도 교수님] 빛으로 뇌 기능, 행동, 감정을 자유롭게 조절한다​ 생명과학과 2021.12.03 226
351 [김학성 교수님] 카이스트, 거대 단백질 구조체를 레고 블록 쌓듯 조립하는 기술 개발 생명과학과 2021.11.24 260
350 [한진희 교수님] 카이스트, 뉴런(신경 세포) 교체에 의한 기억저장 규명 생명과학과 2021.11.24 209
349 [김찬혁 교수님] 카이스트, 면역관문 신호 극복하는 차세대 CAR-T 세포 치료제 개발 생명과학과 2021.11.24 298
348 [김상규 교수님] 식물 유전자 비밀 푸는 김상규 카이스트 교수 생명과학과 2021.11.24 234
347 [이승재 교수님] 건강한 장수를 유도하는 돌연변이 유전자 발굴 생명과학과 2021.11.24 158
346 서성배 교수님(김보람 연수연구원)_제20회 한국 로레알-유네스코 여성과학자상 수상 file 생명과학과 2021.09.27 479
345 2021 대성해강미생물포럼_좌장 조병관 교수, 연사 김대수 교수_21.09.28(화) 13:00~ file 생명과학과 2021.09.13 333
344 2021 Agrwal Award 시상식이 9월 9일(목) 오후 4시_이준혁 학생(정원석 교수) file 생명과학과 2021.09.06 424
343 김대수 교수님_“뇌의 본능적 욕구 참고 기다리는 아이, 사회적으로 성공” 생명과학과 2021.09.06 385
342 양한슬 교수님_ 서경배과학재단 2021년 신진과학자 선정 file 생명과학과 2021.08.31 369
341 이승희 교수님_시각 정보 인식해 행동 결정하는 대뇌 신경회로 과정 밝혀 생명과학과 2021.08.30 215
Board Pagination Prev 1 2 3 4 5 6 7 8 9 10 ... 19 Next
/ 19